Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

July 2, 2021

Primary Completion Date

December 10, 2021

Study Completion Date

December 10, 2021

Conditions

Healthy

Interventions

DRUG

SYNB1934

SYNB1934 is formulated as a nonsterile solution intended for oral administration

DRUG

SYNB1618

SYNB1618 is formulated as a nonsterile solution intended for oral administration

Trial Locations (1)

High Point Clinical Trials Center, High Point